1. Rymen, Daisy, Peanne, Romain, Millón, María B, Foulquier, François, Matthijs, Gert. 2013. MAN1B1 deficiency: an unexpected CDG-II. In PLoS genetics, 9, e1003989. doi:10.1371/journal.pgen.1003989. https://pubmed.ncbi.nlm.nih.gov/24348268/
2. Wang, Xueping, Chen, Bin, Cao, Yifang, He, Yi, Chen, Wei. 2022. Identification of MAN1B1 as a Novel Marker for Bladder Cancer and Its Relationship with Immune Cell Infiltration. In Journal of oncology, 2022, 3387671. doi:10.1155/2022/3387671. https://pubmed.ncbi.nlm.nih.gov/36016584/
3. Wang, Hai-Feng, Wu, Jian-Hui, Gai, Jun-Wei, Ma, Hong-Shun, Feng, Qiang. 2018. MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer. In Gene, 679, 314-319. doi:10.1016/j.gene.2018.09.022. https://pubmed.ncbi.nlm.nih.gov/30218751/
4. Iannotti, Michael J, Figard, Lauren, Sokac, Anna M, Sifers, Richard N. 2014. A Golgi-localized mannosidase (MAN1B1) plays a non-enzymatic gatekeeper role in protein biosynthetic quality control. In The Journal of biological chemistry, 289, 11844-11858. doi:10.1074/jbc.M114.552091. https://pubmed.ncbi.nlm.nih.gov/24627495/
5. Rafiq, Muhammad Arshad, Kuss, Andreas W, Puettmann, Lucia, Ansar, Muhammad, Najmabadi, Hossein. . Mutations in the alpha 1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability. In American journal of human genetics, 89, 176-82. doi:10.1016/j.ajhg.2011.06.006. https://pubmed.ncbi.nlm.nih.gov/21763484/